Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Clinical Cancer Research|2012Cited by 225
Extracellular Generation of Adenosine by the Ectonucleotidases CD39 and CD73 Promotes Dermal FibrosisPatricia Fernández, Edwin S. L. Chan, Miguel Pérez‐Aso et al.|American Journal Of Pathology|2013Cited by 54
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)David R. Wise, Kwok‐Kin Wong, Pratip K. Chattopadhyay et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 9
Expression of CD70 and the TH17 transcription factor RORgammaT in human contact dermatitis.Frank Martiniuk, William R. Levis, David Lee et al.|PubMed|2008Cited by 6
Data from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast CancerSylvia Adams, Sandra Demaria, Lina Kozhaya et al.|Unknown|2023Cited by 0